Recombinant multi-species BAG6 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine BAG6 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene was first characterized as part of a cluster of genes located within the human major histocompatibility complex class III region. This gene encodes a nuclear protein that is cleaved by caspase 3 and is implicated in the control of apoptosis. In addition, the protein forms a complex with E1A binding protein p300 and is required for the acetylation of p53 in response to DNA damage. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
The Alternative Names of target: 2410045D21Rik,BAG family molecular chaperone regulator 6,BAG-6,BAG6,BAT3,BCL2-associated athanogene 6 (BAG-6),Bag6,Bat3,D17H6S52E,D6S52E,G3,HLA-B-associated transcript 3,Large proline-rich protein BAG6,Protein G3,Protein Scythe,Scythe
Go
to BAG6 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-SE1653-Ag-1/ GM-Tg-hg-SE1653-Ag-2 | Human BAG6 protein | Human |
| GM-Tg-rg-SE1653-Ag-1/ GM-Tg-rg-SE1653-Ag-2 | Rat BAG6 protein | Rat |
| GM-Tg-mg-SE1653-Ag-1/ GM-Tg-mg-SE1653-Ag-2 | Mouse BAG6 protein | Mouse |
| GM-Tg-cynog-SE1653-Ag-1/ GM-Tg-cynog-SE1653-Ag-2 | Cynomolgus/Rhesus macaque BAG6 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-SE1653-Ag-1/ GM-Tg-felg-SE1653-Ag-2 | Feline BAG6 protein | Feline |
| GM-Tg-cang-SE1653-Ag-1/ GM-Tg-cang-SE1653-Ag-2 | Canine BAG6 protein | Canine |
| GM-Tg-bovg-SE1653-Ag-1/ GM-Tg-bovg-SE1653-Ag-2 | Bovine BAG6 protein | Bovine |
| GM-Tg-equg-SE1653-Ag-1/ GM-Tg-equg-SE1653-Ag-2 | Equine BAG6 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-SE1653-Ag-1/ GM-Tg-hg-SE1653-Ag-2;
GM-Tg-rg-SE1653-Ag-1/ GM-Tg-rg-SE1653-Ag-2;
GM-Tg-mg-SE1653-Ag-1/ GM-Tg-mg-SE1653-Ag-2; GM-Tg-cynog-SE1653-Ag-1/ GM-Tg-cynog-SE1653-Ag-2; GM-Tg-felg-SE1653-Ag-1/ GM-Tg-felg-SE1653-Ag-2; GM-Tg-cang-SE1653-Ag-1/ GM-Tg-cang-SE1653-Ag-2; GM-Tg-bovg-SE1653-Ag-1/ GM-Tg-bovg-SE1653-Ag-2; GM-Tg-equg-SE1653-Ag-1/ GM-Tg-equg-SE1653-Ag-2 |
| Products Name | BAG6 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | BAG6 |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine BAG6 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.